Bioprocessing White Papers

  1. Successful Commercial Strategy For Advancing A Molecule From The Laboratory To The Clinic
    10/24/2017

    Experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible  without sacrificing product quality, process efficiency, or patient safety.

  2. Laying The Foundation For Viral Safety
    10/20/2017

    Mitigating the risk of viral contamination in vaccines, cell, and gene therapies.

  3. Understanding And Defining Laboratory Capacity In Biopharma
    10/19/2017

    Examine the options available for measuring your laboratory capacity.

  4. Viral Safety In Monoclonal Antibody Manufacturing
    10/19/2017

    Experts share their unique perspectives on the various technologies to prevent, detect, and remove virus contamination.

  5. Advances In Upstream Technologies Reduce Viral-Contamination Risks
    10/18/2017

    Multilayered approach includes virus-resistant CHO cell lines, advanced filtration technologies, and careful raw material selection.

  6. Purification Of Antibody Fragments And Single Domain Antibodies
    10/12/2017

    The wide range of antibody fragment variants for which Amsphere A3 can be used as a capture resin is described, together with insight to the related binding mechanisms obtained via x-ray crystallography.

  7. How Fit Is Your Biopharmaceutical Manufacturing Facility?
    9/7/2017

    How a proactive approach involving predictive — rather than preventive — tools to identify deficiencies before they compound and become actual problems can result in a healthy bioprocessing facility.

  8. How To Overcome Validation Challenges In A Single-Use World
    9/7/2017

    How can end users ensure the expected level of compliance in this new world of single-use systems? The secret: shared responsibility for validation with your supply chain.

  9. Insights And Tips When Addressing Bioburden Challenges
    8/30/2017

    Addresses the challenges associated with the bioburden control process involved in making mAbs or other biologicals, as well as the single-use solutions and improved ways to avoid microbial contamination.

  10. Bioburden: Address Microbial Contamination In Downstream Bioprocessing
    8/30/2017

    A discussion on the risks related to bioburden downstream processing and ways to mitigate them. Topics covered include improvements in raw material, equipment design, and chromatography resin properties.